Keyphrases
Pemphigus Vulgaris
100%
Mycosis Fungoides
55%
Pemphigus
52%
Cutaneous Adverse Drug Reactions (cADRs)
38%
Drug Eruption
30%
Pachyonychia Congenita
27%
Interferon-gamma Release Assay
24%
Pediatric
24%
Response to Treatment
24%
Drug-induced Pemphigus
23%
T Cells
22%
Microsatellite Markers
21%
Bullous Pemphigoid
21%
C-reactive Protein
20%
Jewish Patients
19%
Palmoplantar Keratoderma
19%
Evanescent Wave Spectroscopy
18%
Optical Fiber
18%
Dermatitis
18%
Interferon-γ
18%
Interferon-α (IFN-α)
18%
ST18
18%
Autosomal Recessive Congenital Ichthyosis
18%
Epidermis
16%
Mid-infrared
16%
Clinical Manifestations
15%
Lymphocytes
15%
Release Test
13%
Mucosal Involvement
12%
Blaschko
12%
Beneficial Effects
11%
Autoimmune
11%
Desmoglein 3
11%
Skin Diseases
11%
Skin Cancer
11%
Fourier Transform Infrared Spectroscopy (FT-IR)
11%
Poor Response
11%
Single Center
11%
Epidermal Differentiation
11%
Young children
11%
Human Skin
10%
Jews
10%
Response Predictors
10%
Israeli
10%
Human Leukocyte Antigen
10%
Cellulitis
9%
Jewish
9%
High-resolution
9%
Longitudinal Cohort
9%
Frozen Section
9%
Medicine and Dentistry
Mycosis fungoides
55%
Diseases
54%
Pemphigus
39%
Fiber Optics
27%
Pediatrics
27%
Pachyonychia congenita
27%
Interferon Gamma Release Assay
24%
T Cell
21%
Ichthyosis
21%
In Vitro
20%
Pemphigus vulgaris
20%
Drug Eruption
20%
Palmoplantar Keratoderma
19%
Bullous Pemphigoid
18%
B-Cell Lymphoma
18%
Autosomal Recessive Inheritance
18%
C Reactive Protein
18%
Drug Hypersensitivity
18%
Lymphocyte
15%
Dermatology
14%
Hair Follicle
14%
Disease
14%
Skin Cancer
12%
Darier's Disease
11%
Gamma Interferon
11%
Morphogenesis
11%
Adverse Drug Reaction
10%
Cohort Analysis
10%
Cellulitis
9%
Infrared Fiber
9%
Notch Signaling
9%
Desmoglein 1
9%
Dermatitis
9%
Cancer
9%
Pimecrolimus
9%
Rifampicin
9%
Capillary Hemangioma
9%
Emotional Stress
9%
Synapsin II
9%
Propranolol
9%
Forkhead Transcription Factor
9%
Tinea Capitis
9%
Atopic Dermatitis
9%
Erythema Nodosum
9%
Pigment Disorder
9%
Transient Acantholytic Dermatosis
9%
Pyoderma gangrenosum
9%
Cilazapril
9%
Erdheim-Chester Disease
9%
Lymphoma Cell
9%